For updates on COVID-19, please read.
Our world-class experts. Your child’s care team.
Explore Our Research
Exceptional science. Innovative cures.
Give to our mission.
Why support us? Recognizing World Sickle Cell Day
At age 2, after being diagnosed with sickle cell disease, Aaron-James came to St. Jude where he loves talking to the nurses and doctors.
Read This Patient's Story
Learn more about how you can help protect Memphis from COVID-19 by getting yourself and your loved ones vaccinated.
We have the world's best survival rates for some of the most aggressive cancers.
Join our anniversary year virtually or in-person! Register now for the marathon, half marathon, 10K, 5K or one of our multi-race challenges.
What happens when you give the world’s brightest minds the resources to do something remarkable? Cures.
St. Jude Inspire tells the stories that inspire trust, hope and faith in the mission that drives us: Finding cures. Saving children.
Read our new strategic plan and learn about our bold vision for the future.
Read This Article
Join our nationwide St. Jude Walk/Run during Childhood Cancer Awareness Month this September, and raise funds. With your support, we won’t stop until no child dies from cancer.
Read This Story
We share our research with the world, leading a global effort to understand, treat, and defeat pediatric cancer and other life-threatening diseases.
St. Jude is committed to finding a cure for sickle cell disease. Learn more, and find out ways you can get involved to help patients like Za'Mya.
St. Jude scientists analyzed tumor samples from a 10-year clinical trial that studied medulloblastoma.
Enzyme LRRK2 is a biological switch whose mutation generates abnormal proteins in Parkinson’s patients.
Grief and bereavement expert with years of building social work programs in academia will direct a growing program at
St. Jude looked at sequences of DNA to determine how they can destroy cancer cells that resist treatment.
St. Jude Children's Research Hospital scientists have helped advance a new therapy for sickle cell disease.
St. Jude Children’s Research Hospital provides the first gene therapy manufacturing and distribution cost report for hemophilia B.
More Science & Medicine